A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

SpliceArray Profiling of Breast Cancer Reveals a Novel Variant of NCOR2/SMRT That Is Associated with Tamoxifen Resistance and Control of ER  Transcriptional Activity

(2012) L. Zhang et al.   CANCER RESEARCH

Mammostrat As an Immunohistochemical Multigene Assay for Prediction of Early Relapse Risk in the Tamoxifen Versus Exemestane Adjuvant Multicenter Trial Pathology Study

(2012) John M.S. Bartlett et al.   JOURNAL OF CLINICAL ONCOLOGY

Lost in Translation? Estrogen Receptor Status and Endocrine Responsiveness in Breast Cancer

(2012) Nadia Harbeck et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer

(2012) Susann Busch et al.   PLoS One

Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients

(2012) Nobuhiro Ijichi et al.   Hormones & Cancer

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

(2011) B. Ejlertsen et al.   ANNALS OF ONCOLOGY

Jetset: selecting the optimal microarray probe set to represent a gene

(2011) Qiyuan Li et al.   BMC BIOINFORMATICS

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data

(2011) Balázs Győrffy et al.   BREAST CANCER RESEARCH AND TREATMENT

Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatment

(2011) B. Elsberger et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen

(2011) A. M. Mendes-Pereira et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway

(2011) K. Jin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Patients

(2010) Carol Watson et al.   AMERICAN JOURNAL OF PATHOLOGY

Pharmacogenetics of Endocrine Therapy for Breast Cancer

(2010) Michaela J. Higgins et al.   Annual Review of Medicine

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

(2010) Kirsten Vang Nielsen et al.   BREAST CANCER RESEARCH AND TREATMENT

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

(2010) E. A. Reijm et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2

(2010) Sreenivasan Paruthiyil et al.   BREAST CANCER RESEARCH AND TREATMENT

Combinatorial biomarker expression in breast cancer

(2010) Emad A. Rakha et al.   BREAST CANCER RESEARCH AND TREATMENT

Tubulin-Independent Tau in Alzheimers Disease and Cancer: Implications for Disease Pathogenesis and Treatment

(2010) S. Souter et al.   Current Alzheimer Research

Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer

(2010) W. Fraser Symmans et al.   JOURNAL OF CLINICAL ONCOLOGY

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer

(2010) Yang Li et al.   NATURE MEDICINE

AIB1 is a predictive factor for tamoxifen response in premenopausal women

(2009) S. Alkner et al.   ANNALS OF ONCOLOGY

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial

(2009) Christine Desmedt et al.   BMC Medical Genomics

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

(2009) Balazs Györffy et al.   BREAST CANCER RESEARCH AND TREATMENT

Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients

(2009) L. M. McGlynn et al.   CLINICAL CANCER RESEARCH

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

(2009) Werner Schroth   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples

(2009) Balazs Gyorffy et al.   PLoS One

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

(2008) Sherene Loi et al.   BMC GENOMICS

Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients

(2008) Balazs Györffy et al.   BREAST CANCER RESEARCH AND TREATMENT

Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer

(2008) James J. Dignam et al.   BREAST CANCER RESEARCH AND TREATMENT

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

(2008) Yi Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast

(2008) E K A Millar et al.   BRITISH JOURNAL OF CANCER

Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer

(2008) Elizabeth Iorns et al.   CANCER CELL

RNA-Seq: a revolutionary tool for transcriptomics

(2008) Zhong Wang et al.   NATURE REVIEWS GENETICS